Mojca Skoberne

Title: Innovations of Mojca Skoberne in Vaccine Development

Introduction

Mojca Skoberne is a prominent inventor based in Cambridge, MA, known for her significant contributions to the field of vaccine development. With a total of five patents to her name, she has made remarkable strides in addressing critical health concerns, particularly in the realm of viral infections.

Latest Patents

One of her latest patents focuses on vaccines against herpes simplex virus type 2 (HSV-2). This virus poses a major health concern, and her work provides highly effective vaccines and immunogenic compositions aimed at eliciting an immune response against HSV-2. The antigens developed can be utilized both therapeutically and prophylactically, showcasing her innovative approach to combating viral infections.

Career Highlights

Mojca Skoberne is currently associated with Genocea Biosciences, Inc., where she continues to advance her research and development efforts. Her expertise in immunology and vaccine technology has positioned her as a key player in the fight against infectious diseases.

Collaborations

Some of her notable coworkers include Deborah Long and Jessica Baker Flechtner, who contribute to the collaborative environment that fosters innovation and research excellence.

Conclusion

Mojca Skoberne's work in vaccine development, particularly against HSV-2, highlights her dedication to improving public health through innovative solutions. Her contributions are vital in the ongoing battle against viral infections, and her patents reflect her commitment to advancing medical science.